Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine vs Hydrocodone/Acetaminophen for Pain After Mohs Surgery
NCT07575230Phase 4Enrolling by invitation
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by Baylor Scott & White Research Institute. Started Nov 2025; status: enrolling by invitation.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07575230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575230.